An earlier diagnostic assessment of COVID-19 patients in Wuhan revealed an increase in the levels of cardiac cTnI (a myocardial injury marker >28 pg/mL) in five of the first 41 patients [6,34]. This evidence concerns the gene TNNI3 and COVID-19.